Phenol-derived CVFM analog inhibitors of Ras farnesyltransferase possessing cellular in vitro activity

European Journal of Medicinal Chemistry

Volumn 33, Issue 9, 1998, Pages 725-732

  Caliendo, Giuseppe ^a   Fiorino, Ferdinando ^a   Grieco, Paolo ^a   Perissutti, Elisa ^a   Ramunno, Anna ^a   Santagada, Vincenzo ^a   Albrizio, Stefania ^b   Califano, Daniela ^c   Giuliano, Ada ^c   Santelli, Giovanni ^c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Cellular in vitro activity; Phenol derivative; Ras Farnesyltransferase inhibitor

Indexed keywords

FARNESYL TRANS TRANSFERASE; PROTEIN FARNESYLTRANSFERASE INHIBITOR;

ANIMAL CELL; ARTICLE; CANCER CHEMOTHERAPY; CELL CULTURE; CELL GROWTH; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYME INHIBITION; ESTERIFICATION; HYDROGENATION; NONHUMAN; ONCOGENE RAS; PROTEIN DEGRADATION; PROTEIN PROCESSING; RAT; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION;

EID: 0032440933     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(98)80031-7     Document Type: Article

References (24)

1. [1] IUPAC-IUB Joint Commission on Biochemical Nomenclature, Biochem. J. 219 (1984) 345-373.
2. [2] Bos J.L., Cancer Res. 49 (1989) 4681-4689.
3. [3] Suarez H.G., du Villard J.A., Severino M., Caillou B., Schlumberger M., Tubiana M., Parmentier C., Monier R., Oncogene 5 (1990) 565-570.
4. [4] Newman C.M., Mager A.I., Biochim. Biophys. Acta 1155 (1993) 79-96.
5. [5] Barbacid M., Ann. Rev. Biochem. 56 (1987) 779-827.
6. [6] Kato K., Cox A.D., Hisaka M.M., Graham S.M., Buss J.E., Der C.J., Proc. Natl. Acad Sci. USA 89 (1992) 6403-6407.
7. [7] Khosravi-Far R., Cox A.D., Kato K., Der C.J., Cell Growth Differ. 3 (1992) 461-469.
8. [8] Schafer W.R., Rine J., Annu. Rev. Genet. 26 (1992) 209-237.
9. [9] Reiss Y., Goldstein J.L., Seabra M.C., Casey P.J., Brown M.S., Cell 62 (1990) 81-88.
10. [10] Brown M.S., Goldstein J.L., Paris K.J., Burnier J.P., Marsters J.R., Proc. Natl. Acad. Sci. USA 8 (1992) 8313-8316.
11. [11] Kohl N.E., Mosser S.C., de Solms J., Giuliani E.A., Pompliano D.L., Graham S.L., Smith R.L., Scolnick E.M., Oliff A., Gibbs J.B., Science 260 (1993) 1934-1937.
12. [12] Buss J.E., Marsters J.C., J Chem. Biol. 2 (1995) 787.
13. [13] Leftheris K., Kline T., Vite G.D., Cho Y.H., Bhide R.S., Patel D.V., Patel M.M., Schmidt R.J., Weller H.N., Andahazy M.L., Carboni J.M., Gullo-Brown J.L., Lee F.Y.F., Ricca C., Rose W.C., Yan N., Barbacid M., Hunt J.T., Meyers C.A., Seizinger B.R., Zahler R., Manne V., J. Med. Chem. 39 (1996) 224.
14. [14] Hunt J.T., Lee V.G., Leftheris K., Seizinger B., Carboni J., Mabus J., Ricca C., Yan N., Manne V., J. Med. Chem. 39 (1996) 353.
15. [15] Leonard D.M., Shuler K.R., Poulter C.J., Eaton S.R., Sawyer T.K., Hodges J.C., Su T.Z., Scholten J.D., Gowan R.C., Sebolt-Leopold J.S., Doherty A.M., J. Med. Chem. 40 (1997) 2971-2990.
16. [16] Goldstein J.L., Brown M.S., Stradley S.J., Reiss Y., Gierasch L.M., J. Biol. Chem. 266 (1991) 15575-15578.
17. [17] Gibbs J.B., Oliff A., Ann. Rev. Pharmacol. Toxicol. 37 (1997) 143-166.
18. [18] Qian Y., Sebti S.M., Hamilton A.D., Biopolymers (Pep. Sci.) 43 (1997) 25-41.
19. [19] Patel D.V., Patel M.M., Robinson S.S., Gordon E.M., Bioorg. Med. Chem. Lett. 4 (1994) 1883-1888.
20. [20] Kowalczyk J.J., Ackermann K., Garcia A.M., Lewis M.D., Bioorg. Med. Chem. Lett. 5 (1995) 3073-3078.
21. [21] Hagiwara D., Miyake H., Morimoto H., Murai M., Fujii T., Matsuo M., J. Med. Chem. 35 (1992) 3184-3191.
22. [22] Knorr R., Trzeciak A., Bannwarth W., Gllessen D., Tetrahedron Lett. 30 (1989) 1927-1930.
23. [23] Fusco A., Berlingieri M.T., Di Fiore P.P., Portella G., Grieco M., Vecchio G., Mol. Cell. Biol. 7 (1987) 3365-3370.
24. [24] Manne V., Ricca C.S., Brown J.G., Tuomari A.V., Yan N., Patel D V., Schimdt R., Lingh M.J., Ciosek J., Carboni J.M., Robinson S., Gordon E.M., Barbacid M., Seizinger B.R., Biller S.A., Drug Dev. Res. 38 (1995) 121-137.